These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 30717)

  • 1. Pure crystalline estradiol pellet implantation for contraception.
    Asch RH; Greenblatt RB; Mahesh VB
    Int J Fertil; 1978; 23(2):100-5. PubMed ID: 30717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous implantation of pure crystalline estradiol pellets for conception control.
    Oettinger M; Barak S; Oettinger-Barak O; Ophira E
    Gynecol Obstet Invest; 2005; 59(3):119-25. PubMed ID: 15591820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation of pure crystalline pellets of estradiol for conception control.
    Greenblatt RB; Asch RH; Mahesh VB; Bryner JR
    Am J Obstet Gynecol; 1977 Mar; 127(5):520-4. PubMed ID: 836652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and endocrine studies in menopausal women after estradiol pellet implantation.
    Nagamani M; Lin TJ; McDonough PG; Watatani H; McPherson JC; Mahesh VB
    Obstet Gynecol; 1977 Nov; 50(5):541-7. PubMed ID: 909658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contraception by implantation of estradiol pellets].
    Emperaire JC; Greenblatt RB
    Gynecol Prat; 1969; 20(5):327-35. PubMed ID: 5401913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and gonadal function during the use of progesterone- or progesterone-estradiol-releasing vaginal rings.
    Toivonen J
    Int J Fertil; 1980; 25(2):106-11. PubMed ID: 6117523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol pellet implantation for contraception.
    Greenblatt RB; Hernandez-Ayup S; Bohler CS
    J Reprod Med; 1974 Dec; 13(6):207-8. PubMed ID: 4436848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical study of implanted norethindrone pellets for longterm contraception in women. Program for Applied Research on Fertility Regulation.
    Adv Contracept; 1985 Dec; 1(4):295-304. PubMed ID: 3842220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of estrone and estradiol after implantation of estradiol pellets.
    Bryner JR; Greenblatt RB; Ellegood JO; Mahesh VB
    South Med J; 1979 Jun; 72(6):711-4. PubMed ID: 451659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The low dosis gestagen therapy (author's transl)].
    Mall-Haefeli M; Ludwig KS; Spornitz UM; Uettwiller A
    Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):645-60. PubMed ID: 976705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contraception by cyclic treatment with buserelin and progesterone].
    Wieacker P; Breckwoldt M; Greif M; Geisthövel F
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):135-9. PubMed ID: 1904039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels.
    Stangel-Wojcikiewicz K; Zdebik A; Jach R; Huras H; Wadowska-Jaszczynska K; Radon-Pokracka M; Kempisty-Zdebik E; Ludwin A; Ludwin I
    Neuro Endocrinol Lett; 2012; 33(7):697-702. PubMed ID: 23391877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women.
    Narula RK; Chandra VL; Dugwekar YG; Rahman SA; Laumas KR
    Indian J Med Res; 1975 Nov; 63(11):1620-8. PubMed ID: 1222968
    [No Abstract]   [Full Text] [Related]  

  • 20. Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules.
    Kurunmäki H; Toivonen J; Lähteenmäki P; Luukkainen T
    Contraception; 1985 Mar; 31(3):305-18. PubMed ID: 3922676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.